Lista de obras -

A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness

artículo científico publicado en 2017

A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus

artículo científico publicado en 2014

Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation

artículo científico publicado en 2021

Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions

artículo científico publicado en 2008

Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy

artículo científico publicado en 2011

Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.

artículo científico publicado en 2007

Characterization of functional hepatitis C virus envelope glycoproteins.

artículo científico publicado en 2004

Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus

artículo científico publicado en 2005

Chemobiology at happy hour: yeast as a model for pharmacological screening

artículo científico publicado en 2014

Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans

artículo científico publicado en 2006

Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers

artículo científico

Evaluation of the antiprion activity of 6-aminophenanthridines and related heterocycles

scientific article published on 03 June 2014

Functional hepatitis C virus envelope glycoproteins

artículo científico publicado en 2004

Hepatitis C virus entry: potential receptors and their biological functions

artículo científico publicado en 2006

High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.

artículo científico publicado en 2006

High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.

artículo científico publicado en 2005

High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry.

artículo científico publicado en 2006

Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease

artículo científico publicado en 2008

Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus

artículo científico publicado en 2007

Mitochondrial protein sorting as a therapeutic target for ATP synthase disorders.

artículo científico publicado en 2014

Mode of action of the antiprion drugs 6AP and GA on ribosome assisted protein folding

artículo científico publicado en 2011

Novel cationic bis(acylhydrazones) as modulators of Epstein-Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA

scientific article published on 23 May 2019

Novel endogenous retrovirus in rabbits previously reported as human retrovirus 5.

artículo científico publicado en 2002

Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA

artículo científico publicado en 2017

Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy

scientific article published on 01 May 2019

Procedure for identification and characterization of drugs efficient against mammalian prion: from a yeast-based antiprion drug screening assay to in vivo mouse models

artículo científico publicado en 2009

Protein Folding Activity of the Ribosome is involved in Yeast Prion Propagation

artículo científico publicado en 2016

Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs

artículo científico publicado en 2008

Rabbit endogenous retrovirus-H encodes a functional protease

artículo científico publicado en 2003

Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system

artículo científico publicado en 2006

Structure-activity relationship study around guanabenz identifies two derivatives retaining antiprion activity but having lost α2-adrenergic receptor agonistic activity

artículo científico publicado en 2014

Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus

artículo científico publicado en 2006

Synthesis of conjugates of 6-aminophenanthridine and guanabenz, two structurally unrelated prion inhibitors, for the determination of their cellular targets by affinity chromatography

artículo científico publicado en 2010

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

artículo científico publicado en 2007

The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competition

artículo científico publicado en 2013

The dominant-negative interplay between p53, p63 and p73: A family affair

artículo científico publicado en 2016

The double life of the ribosome: When its protein folding activity supports prion propagation

artículo científico publicado en 2017

The long-lasting love affair between the budding yeast Saccharomyces cerevisiae and the Epstein-Barr virus

artículo científico

The toll-like receptor agonist imiquimod is active against prions

artículo científico publicado en 2013

The various facets of the protein-folding activity of the ribosome

artículo científico publicado en 2011

Tools for the study of ribosome-borne protein folding activity

artículo científico publicado en 2008

Using yeast to model calcium-related diseases: example of the Hailey-Hailey disease.

artículo científico

p53, A Victim of the Prion Fashion

artículo científico publicado en 2021

p53, p63 and p73 in the wonderland of S. cerevisiae

artículo científico publicado en 2017

Lista de obras de

A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness

A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus

Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation

Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions

Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy

Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.

Characterization of functional hepatitis C virus envelope glycoproteins.

Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus

Chemobiology at happy hour: yeast as a model for pharmacological screening

Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans

Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers

Evaluation of the antiprion activity of 6-aminophenanthridines and related heterocycles

Functional hepatitis C virus envelope glycoproteins

Hepatitis C virus entry: potential receptors and their biological functions

High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.

High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.

High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry.

Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease

Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus

Mitochondrial protein sorting as a therapeutic target for ATP synthase disorders.

Mode of action of the antiprion drugs 6AP and GA on ribosome assisted protein folding

Novel cationic bis(acylhydrazones) as modulators of Epstein-Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA

Novel endogenous retrovirus in rabbits previously reported as human retrovirus 5.

Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA

Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy

Procedure for identification and characterization of drugs efficient against mammalian prion: from a yeast-based antiprion drug screening assay to in vivo mouse models

Protein Folding Activity of the Ribosome is involved in Yeast Prion Propagation

Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs

Rabbit endogenous retrovirus-H encodes a functional protease

Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system

Structure-activity relationship study around guanabenz identifies two derivatives retaining antiprion activity but having lost α2-adrenergic receptor agonistic activity

Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus

Synthesis of conjugates of 6-aminophenanthridine and guanabenz, two structurally unrelated prion inhibitors, for the determination of their cellular targets by affinity chromatography

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competition

The dominant-negative interplay between p53, p63 and p73: A family affair

The double life of the ribosome: When its protein folding activity supports prion propagation

The long-lasting love affair between the budding yeast Saccharomyces cerevisiae and the Epstein-Barr virus

The toll-like receptor agonist imiquimod is active against prions

The various facets of the protein-folding activity of the ribosome

Tools for the study of ribosome-borne protein folding activity

Using yeast to model calcium-related diseases: example of the Hailey-Hailey disease.

p53, A Victim of the Prion Fashion

p53, p63 and p73 in the wonderland of S. cerevisiae